Trial reportValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2018
Cost-Effectiveness of a Comprehensive Approach for Hypertension Control in Low-Income Settings in Argentina: Trial-Based Analysis of the Hypertension Control Program in Argentina.
Trial report in Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Economics of Team-Based Care for Blood Pressure Control: Updated Community Guide Systematic Review.American journal of preventive medicine · 2023Pooled it
- Task sharing with non-physician health-care workers for management of blood pressure in low-income and middle-income countries: a systematic review and meta-analysis.The Lancet. Global health · 2019Pooled it
- Trial
- The cost-effectiveness of peer education on medication adherence in the elderly with hypertension: a randomized controlled trial.BMC public health · 2024Trial
- Cost-effectiveness of a Multicomponent Intervention for Hypertension Control in Low-Income Settings in Argentina.JAMA network open · 2021Trial
- Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan, and Sri Lanka.The Lancet. Global health · 2021Trial
- Prevalence of Hearing Impairment in Saudi Arabia: Pathways to Early Diagnosis, Intervention, and National Policy.Healthcare (Basel, Switzerland) · 2025Article
- Article
- Framework for developing cost-effectiveness analysis threshold: the case of Egypt.The Journal of the Egyptian Public Health Association · 2024Article
- Identifying Who Benefits the Most from a Community Health Worker-Led Multicomponent Intervention for Hypertension.International journal of hypertension · 2024Article
- Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension.NPJ digital medicine · 2023Review
- Cost-effectiveness of a centrifugal-flow pump for patients with advanced heart failure in Argentina.PloS one · 2022Article
- Impact of Elevated Systolic Blood Pressure Levels on Mortality and Life Expectancy in Southeast Chinese Residents.Iranian journal of public health · 2021Article
- Observational
- Improving the monitoring of chronic heart failure in Argentina: is the implantable pulmonary artery pressure with CardioMEMS Heart Failure System cost-effective?Cost effectiveness and resource allocation : C/E · 2021Article
- Prevalence and risk factors for hypertension and diabetes among those screened in a refugee settlement in Uganda.Conflict and health · 2021Article
- The cost-effectiveness of hypertension management in low-income and middle-income countries: a review.BMJ global health · 2020Review
- A bibliometric analysis of income and cardiovascular disease: Status, Hotspots, Trends and Outlook.Medicine · 2020Review
- Starting the path of Digital Transformation in Health Innovation in Digital Health: Conference proceeding.Ciencia e innovacion en salud · 2020Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundA recent cluster randomized trial evaluating a multicomponent intervention showed significant reductions in blood pressure in low-income hypertensive subjects in Argentina.
objectivesTo assess the cost-effectiveness of this intervention.
methodsA total of 1432 hypertensive participants were recruited from 18 primary health care centers. The intervention included home visits led by community health workers, physician education, and text messaging. Resource use and quality of life data using the three-level EuroQol five-dimensional questionnaire were prospectively collected. The study perspective was that of the public health care system, and the time horizon was 18 months. Intention-to-treat analysis was used to analyze cost and health outcomes (systolic blood pressure [SBP] change and quality-adjusted life-years [QALYs]). A 1 time gross domestic product per capita per QALY was used as the cost-effectiveness threshold (US $14,062).
resultsBaseline characteristics were similar in the two arms. QALYs significantly increased by 0.06 (95% confidence interval [CI] 0.04-0.09) in the intervention group, and SBP net difference favored the intervention group: 5.3 mm Hg (95% CI 0.27-10.34). Mean total costs per participant were higher in the intervention arm: US $304 in the intervention group and US $154 in the control group (adjusted difference of US $140.18; 95% CI US $75.41-US $204.94). The incremental cost-effectiveness ratio was $3299 per QALY (95% credible interval 1635-6099) and US $26 per mm Hg of SBP (95% credible interval 13-46). Subgroup analysis showed that the intervention was cost-effective in all prespecified subgroups (age, sex, cardiovascular risk, and body mass index).
conclusionsThe multicomponent intervention was cost-effective for blood pressure control among low-income hypertensive patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.